medroxyprogesterone acetate 2.5 MG Oral Tablet
medroxyprogesterone acetate
RxCUI: 1000135
What the CMS Formulary Data Shows for medroxyprogesterone acetate 2.5 MG Oral Tablet
Per the CMS 2026 Part D formulary file, medroxyprogesterone acetate 2.5 MG Oral Tablet (RxNorm concept RXCUI 1000135, generic name medroxyprogesterone acetate) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 2, with a cross-plan average of Tier 1.3.
Real-world access to medroxyprogesterone acetate 2.5 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 108,623 Part D beneficiaries filled medroxyprogesterone acetate 2.5 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $9,563,405 and an average per-beneficiary annual cost of $88.04. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry medroxyprogesterone acetate 2.5 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 330
- Plans covering
- 5,067
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 2
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 108,623
- Total spending
- $9,563,405
- Avg per beneficiary
- $88.04
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering medroxyprogesterone acetate 2.5 MG Oral Tablet
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering medroxyprogesterone acetate 2.5 MG Oral Tablet
98 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is medroxyprogesterone acetate 2.5 MG Oral Tablet covered by Medicare Part D?
Yes, medroxyprogesterone acetate 2.5 MG Oral Tablet is covered by 5,067 Medicare Part D plans (100% of all Part D formularies).
What tier is medroxyprogesterone acetate 2.5 MG Oral Tablet on Medicare Part D plans?
medroxyprogesterone acetate 2.5 MG Oral Tablet averages Tier 1.3 across Part D plans, ranging from Tier 1 to Tier 2.
Does medroxyprogesterone acetate 2.5 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for medroxyprogesterone acetate 2.5 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on medroxyprogesterone acetate 2.5 MG Oral Tablet?
In 2023, total Medicare Part D spending on medroxyprogesterone acetate 2.5 MG Oral Tablet was $9,563,405, covering 108,623 beneficiaries. The average spend per beneficiary was $88.04.
Read our methodology - how this data is sourced, computed, and verified.